| | | NLCS16-210 | | Personalized Medicine in Breast Cancer Risk Prediction, Prognosis and Treatment, Now, In the Future and for Whom Speakers: Chair Laura Fejerman, PhD, UCSF
Dr. Jeffrey Weitzel, M.D. (C) Director, Clinical Cancer Genetics, Professor, City of Hope, Duarte, CA will focus on high penetrance
variants and risk prediction.
* Dr. Laura Esserman, M.D., (C) Director, Carol Franc Buck Breast Care Center, UCSF will discuss targeted screening based on
history, clinical information and genetics
Laura Van¹tveer will talk about precision medicine in breast cancer treatment and prognosis
* Dr. Jeff Tice will talk about prediction models for different racial/ethnic groups and the incorporation of genetics into the models
| | MP3 | | $12.00 | | $12.00 | |